Technical Analysis for CARM - Carisma Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.55 | 0.00% | 0.00 |
CARM closed unchanged on Wednesday, May 8, 2024, on 80 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Low | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -2.82% | |
| Stochastic Reached Oversold | Weakness | -2.82% | |
| Gapped Up | Strength | -2.82% | |
| Oversold Stochastic | Weakness | -2.82% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 20 hours ago |
| 1.5x Volume Pace | about 20 hours ago |
| 10 DMA Resistance | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 1% | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania*, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Solid Tumors Immune System Cell Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Antigen Induced Stem Cells
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Solid Tumors Immune System Cell Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Antigen Induced Stem Cells
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.7662 |
| 52 Week Low | 1.52 |
| Average Volume | 166,940 |
| 200-Day Moving Average | 3.24 |
| 50-Day Moving Average | 2.07 |
| 20-Day Moving Average | 1.69 |
| 10-Day Moving Average | 1.61 |
| Average True Range | 0.13 |
| RSI (14) | 33.77 |
| ADX | 32.84 |
| +DI | 9.70 |
| -DI | 23.80 |
| Chandelier Exit (Long, 3 ATRs) | 1.66 |
| Chandelier Exit (Short, 3 ATRs) | 1.91 |
| Upper Bollinger Bands | 1.92 |
| Lower Bollinger Band | 1.46 |
| Percent B (%b) | 0.19 |
| BandWidth | 26.86 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.0082 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.69 | ||||
| Resistance 3 (R3) | 1.69 | 1.65 | 1.66 | ||
| Resistance 2 (R2) | 1.65 | 1.62 | 1.65 | 1.65 | |
| Resistance 1 (R1) | 1.60 | 1.59 | 1.58 | 1.60 | 1.65 |
| Pivot Point | 1.56 | 1.56 | 1.55 | 1.56 | 1.56 |
| Support 1 (S1) | 1.51 | 1.53 | 1.49 | 1.51 | 1.45 |
| Support 2 (S2) | 1.47 | 1.50 | 1.47 | 1.45 | |
| Support 3 (S3) | 1.42 | 1.47 | 1.44 | ||
| Support 4 (S4) | 1.42 |
